Showing results (1281-1290 of 4,516) with videos related to
Sort By:
Pageof 452
Future Oncology (London, England)|January 13, 2022
Outcomes of sorafenib treatment of advanced renal cell carcinoma according to IMDC risk criteria: analysis of Japanese real-world data from postmarketing all-patient surveillance of sorafenibTeruo Inamoto, Haruhito Azuma, Masatoshi Adachi, et al.Future Oncology (London, England)|March 12, 2021
Risk tolerance in adjuvant and metastatic melanoma settings: a patient perspective study using the threshold techniqueCarol Mansfield, Kelley Myers, Kathleen Klein, et al.Future Oncology (London, England)|December 8, 2021
Influence of clear cell carcinoma on the post-hepatectomy prognosis of patients with hepatocellular carcinomaYongheng Deng, Shaoliang Zhu, Wen Yan, et al.Future Oncology (London, England)|December 9, 2021
The treatment of advanced pulmonary sarcomatoid carcinomaYue Zheng, Yang Fu, Qin Zhong, et al.Future Oncology (London, England)|March 5, 2021
Atezolizumab and bevacizumab for hepatocellular carcinoma: mechanism, pharmacokinetics and future treatment strategiesXiufeng Liu, Yi Lu, Shukui QinFuture Oncology (London, England)|March 5, 2021
Chart review of diagnostic methods, baseline characteristics and symptoms for European patients with pancreatic cancerAlfredo Carrato, Davide Melisi, Gerald Prager, et al.Future Oncology (London, England)|November 4, 2021
Dedifferentiated chondrosarcoma: current standards of careAbhay K Kattepur, Robin L Jones, Aashish GuliaFuture Oncology (London, England)|October 10, 2022
Immunotherapy for liposarcoma: emerging opportunities and challengesZhengqing Song, Lili Lu, Zixu Gao, et al.Future Oncology (London, England)|October 6, 2022
SOLTI-1904 ACROPOLI TRIAL: efficacy of spartalizumab monotherapy across tumor-types expressing high levels of PD1 mRNAAleix Prat, Luis Paz-Ares, Manel Juan, et al.Future Oncology (London, England)|September 6, 2022
Application of Cherenkov radiation in tumor imaging and treatmentShao Bianfei, Liu Fang, Xiang Zhongzheng, et al.Pageof 452